Clinical Immunology Articles & Analysis
17 news found
From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. ...
GAITHERSBURG, Md., Dec. 12, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced preliminary Phase 1/2 results from an ongoing study of NEXI-002, a patient-derived ...
“We are very excited to see early signs of clinical activity in the TG4050 clinical trials that uses our AI-driven neoantigen prediction system. ...
” By incorporating Nebion’s public datasets with data Immunai has gathered, Jacobstein said, Immunai will be able to expand its Annotated Multiomic Immunological Cell Atlas (AMICA), the company’s harmonized single-cell immunology database, with advanced transfer and multi-task learning algorithms. ...
ByImmunai
Initial clinical data from the trial are expected in 2022. EO2463 is an innovative, off-the-shelf microbiome-peptide based cancer vaccine that combines four microbiome-peptides of B lymphocyte-specific lineage markers. ...
ByEnterome
Massari is based in Boston and will oversee clinical development and contribute to expanding the company’s AI platform and therapeutic portfolio. “In a short period of time, our artificial intelligence platform has unlocked dozens of novel therapeutic opportunities for addressing patients with rare genetic disorders,” said Brendan Frey, Founder and Chief ...
Curtis, Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB), and national Co-Principal Investigator for SetPoint Medical’s upcoming pivotal trial of VNS in patents with RA. ...
Curtis, Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB), and national Co-Principal Investigator for SetPoint Medical’s upcoming pivotal trial of VNS in patents with RA. ...
Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out millions of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. The company is also announcing $20M in seed funding, which will be used to further the development of its technology and business functions ...
ByImmunai
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. ...
As pioneers of products that assist in ground-breaking discoveries in science and clinical care, we have a strong network of academic and industry partners. ...
ByBaker
This was reflected by the huge amount of international professional visitors of this year’s annual EAACI 2019 (congress of the European Academy of Allergy and Clinical immunology) taking place in Portugal’s capital and harbor city Lisbon. ...
If we want to protect children, we have to protect pregnant women," says the study's senior author Rachel Miller, MD, professor of Medicine (in Pediatrics) and Environmental Health Sciences; and chief of Pediatric Allergy, Immunology, and Rheumatology at Columbia University Medical Center; and co-deputy director of the Columbia Center for Children's Environmental Health at ...
Earlier studies have shown that ANA can actually develop many years before the clinical appearance of autoimmune diseases, such as type 1 diabetes, lupus, and rheumatoid arthritis. ...
The NHLBI will soon launch a network of six clinical centers that will integrate molecular, cellular and clinical studies of severe asthma to better predict when serious complications of asthma will occur and identify new targets for therapy. ...
The NHLBI will soon launch a network of six clinical centers that will integrate molecular, cellular and clinical studies of severe asthma to better predict when serious complications of asthma will occur and identify new targets for therapy. ...
The research, which was funded by the National Institutes of Health and appears in the Journal of Allergy and Clinical Immunology, is the first to use a nationally representative sample, as well as specific immunoglobulin E (IgE) or antibody levels to quantify allergic sensitization to common foods, including peanuts, milk, eggs, and shrimp. ...